Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or…
GlobeNewswire, Inc.
BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that...
Former Met Police Detective Inspector and Recruitment Expert Launch Career Transition Programme for UK Police Leavers
EIN Presswire
UK, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ -- Blue Light Transition, founded by retired Detective Inspector Janet Barr and recruitment professional Tommy Jones, has launched the Badge to Boardroom programme — a six-step career...
CDAO Financial Services & Insurance UK
EIN Presswire
CDAO Financial Services & Insurance UK Returns to London, Bringing Together the Leaders Shaping the Future of Data, Governance, and Analytics LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ -- As financial institutions face growing...
AI in Finance Summit London Returns to Help Financial Institutions Scale AI from Pilot to Production
EIN Presswire
LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ -- As financial institutions accelerate enterprise AI adoption, the AI in Finance Summit London returns for its 11th edition, bringing together senior AI, data, technology, and...
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
~ 2026 Second Quarter Net Product Sales of $17.1 Million, Up 78% Year over Year ~ ~ 2026 Second Quarter Non-GAAP Adjusted EBITDA of $2.8 Million ~ ~ Record PEDMARK® Demand Carried into Third Quarter 2026 as Field Sales Expansion Efforts Continue...
Senior Executives Turn to Portfolio Careers as UK Redundancy Warnings Hit Five-Year High
EIN Presswire
The Portfolio Executives opens registration for its free Fractional Executive Jumpstart programme as UK job cuts reshape senior careers.
Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire, Inc.
Company reports AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $45.7 million in Q2 2026, an increase of 119% year-over-year FY 2026 net product revenue guidance increased to $140 - $150 million Gross margin increased in Q2...
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Multiple scientific data presentations, including five oral presentations across three programs, at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, France New clinical data on HMB-002 demonstrated 2.4-fold...
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027 Phase 1 Data Presented at European Hematology Association (EHA) 2026 Congress Further Support...
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire, Inc.
VANCOUVER, British Columbia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics,...
XRPPower Launches Advanced AI-Powered Financial Intelligence Platform to Deliver Smarter Financial Solutions Worldwide
GlobeNewswire, Inc.
London, UK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- As the global economy continues to evolve, individuals and businesses are increasingly looking for intelligent financial solutions that can simplify decision-making, improve efficiency, and support...
UCLOUDLINK GROUP INC. to Report Second Quarter 2026 Financial Results on August 18, 2026
GlobeNewswire, Inc.
HONG KONG, Aug. 11, 2026 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will report its unaudited financial...
Further Blow to UK Universities
GlobeNewswire, Inc.
LONDON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- More than 90% of young people would consider an apprenticeship over a university degree, a new survey from the skills charity Enginuity has revealed.
USA Rare Earth Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
STILLWATER, Okla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), (USAR), a rare earth, critical minerals and advanced materials company, today announced its financial and operational results for the second...
Greystone Housing Impact Investors Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
OMAHA, Neb., Aug. 10, 2026 (GLOBE NEWSWIRE) -- On August 10, 2026, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended June 30, 2026. The Partnership also announced it will...
Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire, Inc.
One-year REMAIN-1 Midpoint Cohort data show Revita patients maintained up to 84% of prior GLP-1-induced weight loss versus 46% with sham in patients receiving complete duodenal ablations — the first randomized evidence of durable, drug-free weight...
Public Policy Holding Company, Inc. Announces Q2 2026 Financial Results
GlobeNewswire, Inc.
Continued Revenue Growth and Disciplined M&A Execution in First Half of 2026; Raises Full Year 2026 Guidance to Reflect Recent Acquisitions H1 2026 revenue growth of 16.3% with organic revenue growth of 4.4%, compared to H1 2025 Completed one...
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
GlobeNewswire, Inc.
- $243.7 million in total second quarter revenues, primarily comprised of $222.4 million of U.S. Attruby® net product revenue, with growth led by the treatment-naïve segment as physicians increasingly start and keep patients on Attruby - Attruby...
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire, Inc.
Continued progress toward starting SC451 Phase 1/2 trial, including GLP toxicology studies, SC451 process transfer to the contract manufacturer, and clinical trial readiness Continued progress toward starting clinical study for SG293 in...
Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
Remains on track to submit investigational new drug (IND) application in 4Q 2026 for the global clinical program of MGX-001 for the treatment of hemophilia A $120.7 million in cash, cash equivalents, and available-for-sale marketable securities as...
Sign up for:
Fintech Reporter UK
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.